Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-CD19 allo-CAR-T in relapsed B-cell malignancies post-HSCT
NCT04516551Phase 1Unknown
- Sponsor
- Xinqiao Hospital
- Start
- Nov 2020
- Primary completion
- Dec 2021
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
Phase 1, open-label trial of GC007g in acute lymphoblastic leukemia (ALL), sponsored by Xinqiao Hospital. Status: unknown.
02
Drugs
GC007g
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT04516551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04516551.